Literature DB >> 12606628

Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.

Hazel H Szeto1, Yi Soong, Dunli Wu, XuanXuan Qian, Guo-Min Zhao.   

Abstract

[Dmt(1)]DALDA (H-Dmt-d-Arg-Phe-Lys-NH(2); Dmt = 2',6'-dimethyltyrosine) is a dermorphin analog that shows high affinity and selectivity for the mu opioid receptor. The intrathecal potency of [Dmt(1)]DALDA far exceeded its affinity at mu receptors and suggests that other mechanisms must be involved in its action in the spinal cord. The affinity and selectivity of [Dmt(1)]DALDA was determined using cell membranes expressing cloned human mu, delta, and kappa opioid receptors. Competitive displacement binding with [(3)H][Dmt(1)]DALDA, [(3)H]DPDPE (H-Tyr-d-Pen-Gly-Phe-d-Pen), and [(3)H]U69,593 [(5alpha,7alpha,8beta)-(+)-N-methyl-N-(7-[1-pyrrolidinyl]-1-oxaspiro[4.5]dec-8-yl)-benzeneacetamide] revealed K(i) of 156 +/- 26 pM for mu opioid receptor (MOR), 1.67 +/- 0.04 microM for delta opioid receptor (DOR), and K(i) of 4.4 +/- 1.7 nM for kappa opioid receptor (KOR), respectively. [Dmt(1)]DALDA increased guanosine 5'-O-(3-[(35)S]thiotriphosphate) binding in MOR, DOR, and KOR membranes, with EC(50) being 17 (8.8-33) nM, 2 (1.2-3.2) microM, and 124 (15-1000) nM, respectively. Intrathecal [Dmt(1)]DALDA inhibited the tail-flick response in mice with ED(50) = 1.22 (0.59-2.34) pmol. Intrathecal administration of an antiserum against dynorphin A(1-17) or [Met(5)]enkephalin significantly attenuated the response to i.t. [Dmt(1)]DALDA, resulting in ED(50) of 6.2 (3.6-12.6) pmol and 6.6 (3.5-19.6) pmol, respectively. Neither antisera had any effect on the response to i.t. morphine. Intracerebroventricular (i.c.v.) [Dmt(1)]DALDA was not affected by previous i.c.v. administration of anti-Dyn or anti-ME. Pretreatment with norbinaltorphimine or naltriben also attenuated the antinociceptive response to i.t., but not i.c.v., [Dmt(1)]DALDA. These data suggest that i.t. [Dmt(1)]DALDA causes the release of dynorphin and [Met(5)]enkephalin-like substances that act at kappa and delta receptors, respectively, to contribute to the extraordinary potency of [Dmt(1)]DALDA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12606628     DOI: 10.1124/jpet.102.048561

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  [Dmt(1)]DALDA analogues with enhanced μ opioid agonist potency and with a mixed μ/κ opioid activity profile.

Authors:  Longxiang Bai; Ziyuan Li; Jiajia Chen; Nga N Chung; Brian C Wilkes; Tingyou Li; Peter W Schiller
Journal:  Bioorg Med Chem       Date:  2014-02-19       Impact factor: 3.641

2.  Unexpected opioid activity profiles of analogues of the novel peptide kappa opioid receptor ligand CJ-15,208.

Authors:  Jane V Aldrich; Santosh S Kulkarni; Sanjeewa N Senadheera; Nicolette C Ross; Kate J Reilley; Shainnel O Eans; Michelle L Ganno; Thomas F Murray; Jay P McLaughlin
Journal:  ChemMedChem       Date:  2011-07-14       Impact factor: 3.466

Review 3.  Opioid peptide-derived analgesics.

Authors:  Peter W Schiller
Journal:  AAPS J       Date:  2005-10-14       Impact factor: 4.009

4.  Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviour.

Authors:  J V Aldrich; S N Senadheera; N C Ross; K A Reilley; M L Ganno; S E Eans; T F Murray; J P McLaughlin
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

Review 5.  Bi- or multifunctional opioid peptide drugs.

Authors:  Peter W Schiller
Journal:  Life Sci       Date:  2009-03-11       Impact factor: 5.037

6.  The effect of adjuvant midazolam compared with fentanyl on the duration of spinal anesthesia with 0.5% bupivacaine in opium abusers.

Authors:  Farhad Safari; Ali Dabbagh; Mansour Sharifnia
Journal:  Korean J Anesthesiol       Date:  2012-12-14

7.  Effectiveness of local anesthesia with lidocaine in chronic opium abusers.

Authors:  Amir Masoud Hashemian; Ali Omraninava; Ali Darvishpoor Kakhki; Mohammad Davood Sharifi; Koorosh Ahmadi; Babak Masoumi; Omid Mehrpour
Journal:  J Emerg Trauma Shock       Date:  2014-10

8.  Effects of opium addiction on level of sensory block in spinal anesthesia with bupivacaine for lower abdomen and limb surgery: a case-control study.

Authors:  Seyyed Hasan Karbasy; Pooya Derakhshan
Journal:  Anesth Pain Med       Date:  2014-11-26

9.  Comparison of Duration of Spinal Anesthesia with Lidocaine or Lidocaine plus Epinephrine between Addicts and Non-addicts.

Authors:  Afshin Mansourian; Mohammad Askarzadeh; Mohammad Shabani; Kouros Divsalar
Journal:  Addict Health       Date:  2012 Summer-Autumn

10.  Performance of Local Anesthesia with Lidocaine among Opium Addicts and Non-Addicts; a Case Control Study.

Authors:  Alireza Majidi; Tala Shahhosseini; Sadrolla Mahmoudi
Journal:  Emerg (Tehran)       Date:  2018-06-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.